MZF1 and melanoma: In the GSE91061 melanoma cohort, found that MZF1 expression was negatively correlated with response to anti-PD-1 treatment, with patients exhibiting lower MZF1 expression showing significantly better survival outcomes than those with higher MZF1 expression (Figure 6C).